Serenella Tolomeo

Dr Serenella Tolomeo is a Senior Scientist at the Institute of High Performance Computing and Institute for Human Development and Potential (A*STAR). Her research focuses on determining brain pathophysiological mechanisms underlying psychiatric and addictive disorders. Her research goals integrate preclinical studies and clinical psychiatry, using neuroimaging (fMRI, rsfMRI, sMRI and MR Spectroscopy) and decision-making neuroscience measures. Her commitment is to impact the translational psychiatry research area in the long term. She has been collaborating with various pharmaceutical companies, such as Lundbeck, Merck Serono and Indivior. She authored a number of Q1 journals such as Brain, Neuroscience and Biobehavioral Reviews, Biological Psychiatry: CNNI, Psychological Medicine, Human Brain Mapping, Neuroimage: Clinical, Nature - Translational Psychiatry / Scientific Reports, Progress in Neuro-Psychopharmacology & Biological Psychiatry, Schizophrenia, SCAN and Journal of affective disorders. She has been the recipient of multiple awards. Areas of specific expertise from clinical research and clinical practice include bipolar disorder, major depressive disorder, schizophrenia and substance use disorder.